Ganapathy Kavya, Harrs Christian F, Harris Samuel, Staklinski Stephen J, Khatib Ayman, Park Jong Y, Chakrabarti Ratna
Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA.
Moffitt Cancer Center, Tampa, FL, USA.
Heliyon. 2025 Jan 23;11(3):e41948. doi: 10.1016/j.heliyon.2025.e41948. eCollection 2025 Feb 15.
Promoter hypermethylation is one of the events that downregulate microRNAs (miRNA), resulting in the differential expression of genes implicated in the progression of cancer. We previously reported that microRNAs (miRNA)-299-3p and -30e target androgen receptor (AR) and are downregulated in advanced prostate cancer (PCa). Here we report that miR-34c, an AR targeting miRNA and miR-299-3p, both are differentially downregulated in PCa cells from African American (AA) and Caucasian American (CA) patients due to disparate promoter hypermethylation in these miRNA genes.
We performed bisulfite sequencing based promoter methylation analysis with or without treatment with DNA methyl transferase (DNMT) inhibitor 5-Aza-2'-deoxycytidine (AzaC). Luciferase reporter assays and RNA pulldown assays are conducted for miRNA -DNMT interaction analysis. We performed DNMT activity assays and ectopic expression of miRNAs to study their effects.
We observed higher promoter methylation of these miRNA genes in cells derived from an AA patient compared to cells of CA origin, which can be reversed through AzaC treatment. Differential expression and activity of DNMT3A and 3B are noted in PCa cells from AA and CA origins. Immunoprecipitation of Ago revealed bound DNMT3A and 3B mRNAs with miRs-299-3p and -30e in the RISC. Luciferase reporter assays confirmed binding of miRs-299-3p and -30e to the UTRs of DNMT3A and 3B mRNAs. Overexpression of miRs-299-3p and -30e downregulated DNMT3A/B mRNA and protein expression and DNMT activity of DNMTs. Ectopic expression of miR-299-3p restored expression of miRs-34c and -30e in PCa cells. Similarly, overexpression of miR-30e restored expression of miRs-34c and -299-3p.
Our study provides evidence that ectopic expression of miRs-30e and -299-3p restore the loss of expression of miRs-299-3p and -34c miRNAs mediated by DNMT-induced promoter hypermethylation. This study establishes a feedback regulation between AR targeting miRNAs and DNMTs in PCa cells and provides an insight into the mechanism of the aberrant expression of AR in advanced PCa that is potentially mediated through the downregulation of miRs-299-3p, -34c and -30e and stabilization of expression and activities of DNMTs.
启动子高甲基化是导致微小RNA(miRNA)下调的事件之一,从而导致与癌症进展相关基因的差异表达。我们之前报道过,微小RNA(miRNA)-299-3p和-30e靶向雄激素受体(AR),并在晚期前列腺癌(PCa)中下调。在此我们报道,miR-34c(一种靶向AR的miRNA)和miR-299-3p在非裔美国(AA)和欧裔美国(CA)患者的PCa细胞中均因这些miRNA基因不同的启动子高甲基化而差异下调。
我们对经或未经DNA甲基转移酶(DNMT)抑制剂5-氮杂-2'-脱氧胞苷(AzaC)处理的样本进行了基于亚硫酸氢盐测序的启动子甲基化分析。进行荧光素酶报告基因检测和RNA下拉实验以分析miRNA-DNMT相互作用。我们进行了DNMT活性检测和miRNA的异位表达以研究其作用。
我们观察到,与CA来源的细胞相比,AA患者来源的细胞中这些miRNA基因的启动子甲基化程度更高,而AzaC处理可逆转这种情况。在AA和CA来源的PCa细胞中,DNMT3A和3B的表达和活性存在差异。AGO免疫沉淀显示,在RNA诱导沉默复合体(RISC)中,DNMT3A和3B的mRNA与miRs-299-3p和-30e结合。荧光素酶报告基因检测证实miRs-299-3p和-30e与DNMT3A和3B mRNA的非翻译区(UTR)结合。miRs-299-3p和-30e的过表达下调了DNMT3A/B mRNA和蛋白表达以及DNMT的活性。miR-299-3p的异位表达恢复了PCa细胞中miRs-34c和-30e的表达。同样,miR-30e的过表达恢复了miRs-34c和-299-3p的表达。
我们的研究提供了证据,证明miRs-30e和-299-3p的异位表达恢复了由DNMT诱导的启动子高甲基化介导的miRs-299-3p和-34c miRNA表达缺失。本研究确立了PCa细胞中靶向AR的miRNA与DNMT之间的反馈调节,并深入了解了晚期PCa中AR异常表达的机制,这可能是通过miRs-299-3p、-34c和-30e的下调以及DNMT表达和活性的稳定介导的。